Institutional investors purchased a net $1.1 million shares of AEGR during the quarter ended December 2013, and now own 104.46% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 15.0 Thousand shares of Aegerion Pharmaceuticals ...